This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Surgery, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

How Are We Doing?

Mark H. Whiteford, MD; Kenneth R. Stevens, Jr, MD; Steven Oh; Karen E. Deveney, MD

Arch Surg. 2001;136:886-891.

Hypothesis  The adaptation of new techniques in treatment of epidermoid carcinoma of the anal canal during the past 3 decades has improved clinical outcomes.

Design  Retrospective consecutive case review.

Setting  A university hospital and Veterans Affairs medical center.

Patients  Medical records of 76 consecutive patients treated for invasive epidermoid cancer of the anal canal between 1970 and 1999 were reviewed. Twenty-one patients were excluded because of inadequate staging information and/or follow-up of less than 12 months.

Main Outcome Measures  Locoregional recurrence, survival, colostomy-free survival, and morbidity.

Results  Fifty-five patients composed the study population. Ten were treated during decade 1 (1970-1979), 16 in decade 2 (1980-1989), and 29 in decade 3 (1990-1999). Mean age and sex distributions were similar. The prevailing primary treatment modality changed during the course of the study from sequential treatment (chemotherapy then radiation therapy then radical surgery) to concurrent chemoradiation (70% and 0% of cases, respectively, in decade 1 to 7% and 76% of cases, respectively, in decade 3). Locoregional control (50%, 81%, and 93%; P = .01), crude survival (median, 28, 30, and 76 months), and colostomy-free survival (mean, 13, 90, and 80 months) improved during the 3 decades. There were no differences in major complications during the 3 decades (40%, 56%, and 41%).

Conclusion  Primary treatment with concurrent chemoradiation has improved the local recurrence, survival, and colostomy-free survival rates in patients with invasive epidermoid carcinoma of the anal canal without increasing major morbidity.

From the Departments of Surgery (Drs Whiteford and Deveney) and Radiation Oncology (Dr Stevens and Mr Oh), Oregon Health Sciences University and Veterans Affairs Medical Center, Portland.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLES

This Month in Archives of Surgery
Arch Surg. 2001;136(8):859.
FULL TEXT  

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(8):969-970.
FULL TEXT